The Food and Drug Administration is dealing with a flood of inaccurate coronavirus antibody tests after it allowed more than 120 manufacturers and labs to bring the tests to market without an agency review. The tests, which look for antibodies that reveal whether a person has been exposed to the virus, have been eyed as…
Blood tests that measure a person’s antibodies to the coronavirus could be a powerful tool to determine when it’s safe to reopen the country. But concerns about the accuracy and availability of the tests — which detect whether a person has ever been exposed to the virus, and are different from the tests used to…
FDA Commissioner Stephen Hahn has acknowledged the need to ramp up testing, but on Sunday his tone was cautious: Having an inaccurate test is worse than not having a test at all. Going forward, Hahn said on ABC’s “This Week,” “further ramping up testing, both diagnostic as well as the antibody tests, will really be…